BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 29845270)

  • 1. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1.
    Chen C; Ju R; Zhu L; Li J; Chen W; Zhang DC; Ye CY; Guo L
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):423-433. PubMed ID: 28124088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
    Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
    Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
    Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
    Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis.
    Liu H; Li L; Zou J; Zhou T; Wang B; Sun H; Yu S
    BMC Complement Altern Med; 2019 Oct; 19(1):267. PubMed ID: 31615487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice.
    Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C
    Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
    Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
    Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.
    Bowen TS; Adams V; Werner S; Fischer T; Vinke P; Brogger MN; Mangner N; Linke A; Sehr P; Lewis J; Labeit D; Gasch A; Labeit S
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):939-953. PubMed ID: 28887874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
    Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
    Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
    Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
    Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M
    Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.
    Cai D; Frantz JD; Tawa NE; Melendez PA; Oh BC; Lidov HG; Hasselgren PO; Frontera WR; Lee J; Glass DJ; Shoelson SE
    Cell; 2004 Oct; 119(2):285-98. PubMed ID: 15479644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.
    Zhou X; Wang JL; Lu J; Song Y; Kwak KS; Jiao Q; Rosenfeld R; Chen Q; Boone T; Simonet WS; Lacey DL; Goldberg AL; Han HQ
    Cell; 2010 Aug; 142(4):531-43. PubMed ID: 20723755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.